<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02543437</url>
  </required_header>
  <id_info>
    <org_study_id>SJCR-OR-1002</org_study_id>
    <nct_id>NCT02543437</nct_id>
  </id_info>
  <brief_title>Large Head X3 Study</brief_title>
  <official_title>The Effect of Large Diameter Head to Prevent Dislocation, and of 3 rd Generation Highly Crosslinked Polyethylene to Reduce Wear in Computer Assisted Total Hip Arthroplasty.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Japan K.K.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Japan K.K.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to explore the benefit of X3 polyethlene inserts with larger
      diameter heads used in the Japanese population. Range of Motion (ROM) and lift-off distance
      for both 28mm, 32mm and 36mm in patients will be examined intraoperatively by using the
      Stryker computerized tomography (CT) based Navigation system. Another aspect of this study is
      to observe wear resistance performance of X3 over historical liner existing highly
      crosslinked polyethylene.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Range of Motion(ROM) (Degree)</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Measure and compare the ROM using femoral head trials of 36mm- and 28mm-diameter during intraoperative confirmation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lift Off Distance in Dislocation Maneuver(mm)</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Measure and compare the lift off distance in dislocation maneuver using femoral head trials of 36mm- and 28mm-diameter during intraoperative confirmation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wear Rate(%)</measure>
    <time_frame>1 year, 2 years, 3 years and 5 years after surgery</time_frame>
    <description>Retrospective comparison of the wear amount over time between X3 liner and Crossfire insert.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Degenerative Joint Disease</condition>
  <arm_group>
    <arm_group_label>Trident Acetabular X3 Insert</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>28mm, 32mm and 36mm liner</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trident Acetabular X3 Insert</intervention_name>
    <arm_group_label>Trident Acetabular X3 Insert</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient who is a candidate for primary total hip arthroplasty (THA) with cementless
             acetabular and femoral components.

          2. Patient who has diagnosis of degenerative joint disease and no bacterial infectious
             disease.

          3. Patient whose age is 20 or over.

          4. Patient who signed an Institutional Review Board (IRB)-approved, study specific
             Informed Patient Consent Form.

          5. Patient who is willing and able to comply with postoperative scheduled evaluations.

        Exclusion Criteria:

          1. Patient who has a bacterial infectious disease or has a high risk of a bacterial
             infection.

          2. Patient who requires revision surgery of a previously implanted total hip
             arthroplasty.

          3. Patient who is morbidly obese, defined as having a Body Mass Index (BMI) &gt; 45.

          4. Patient who is or may be pregnant female.

          5. Patient who has a neuromuscular or neurosensory deficiency, which limits ability to
             evaluate the safety and efficacy of the device.

          6. Patient with diagnosed systemic disease (i.e. Paget's disease, renal osteodystrophy).

          7. Patient who is immunologically suppressed or receiving chronic steroids.

          8. Patient who is judged ineligible with specific reason by primary doctor.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nagoya Kyoritsu Hospital</name>
      <address>
        <city>Nagoya City</city>
        <state>Aichi</state>
        <zip>454-0933</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yokohama City University Hospital</name>
      <address>
        <city>Yokohama</city>
        <state>Kanagawa</state>
        <zip>236-0004</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyowakai Hospital.</name>
      <address>
        <city>Suita City</city>
        <state>Osaka</state>
        <zip>564-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka City General Hospital.</name>
      <address>
        <city>Osaka</city>
        <zip>534-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2015</study_first_submitted>
  <study_first_submitted_qc>September 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2015</study_first_posted>
  <results_first_submitted>September 25, 2015</results_first_submitted>
  <results_first_submitted_qc>March 7, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 6, 2016</results_first_posted>
  <last_update_submitted>March 7, 2016</last_update_submitted>
  <last_update_submitted_qc>March 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>117 participants / 120 hips enrolled in study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Trident Acetabular X3 Insert</title>
          <description>Trident Acetabular X3 Insert 28mm, 32mm and 36mm liner</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="117"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="117"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>X3 Liner</title>
          <description>X3 28mm, 32mm and 36mm liner
Trident Acetabular X3 Insert</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="117"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.3" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Japan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Range of Motion(ROM) (Degree)</title>
        <description>Measure and compare the ROM using femoral head trials of 36mm- and 28mm-diameter during intraoperative confirmation.</description>
        <time_frame>Intraoperative</time_frame>
        <population>Comparison between 28mm liner and 36mm line. Participants with available data : 119 hips in 117 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>X3 Liner</title>
            <description>X3 28mm, 32mm and 36mm liner
Trident Acetabular X3 Insert</description>
          </group>
        </group_list>
        <measure>
          <title>Range of Motion(ROM) (Degree)</title>
          <description>Measure and compare the ROM using femoral head trials of 36mm- and 28mm-diameter during intraoperative confirmation.</description>
          <population>Comparison between 28mm liner and 36mm line. Participants with available data : 119 hips in 117 participants.</population>
          <units>Degree</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="117"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Hips</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Maximam Flexion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Maximam Extension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Maximam Abduction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lift Off Distance in Dislocation Maneuver(mm)</title>
        <description>Measure and compare the lift off distance in dislocation maneuver using femoral head trials of 36mm- and 28mm-diameter during intraoperative confirmation.</description>
        <time_frame>Intraoperative</time_frame>
        <population>participants with available data : 100 hips in 100 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>X3 Liner</title>
            <description>X3 28mm, 32mm and 36mm liner
Trident Acetabular X3 Insert</description>
          </group>
        </group_list>
        <measure>
          <title>Lift Off Distance in Dislocation Maneuver(mm)</title>
          <description>Measure and compare the lift off distance in dislocation maneuver using femoral head trials of 36mm- and 28mm-diameter during intraoperative confirmation.</description>
          <population>participants with available data : 100 hips in 100 participants.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Hips</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cup inclination</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cup anteversion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stem anteversion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wear Rate(%)</title>
        <description>Retrospective comparison of the wear amount over time between X3 liner and Crossfire insert.</description>
        <time_frame>1 year, 2 years, 3 years and 5 years after surgery</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Adverse Events were not collected.</desc>
      <group_list>
        <group group_id="E1">
          <title>X3 Liner</title>
          <description>X3 28mm, 32mm and 36mm liner
Trident Acetabular X3 Insert</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Yasuyuki Inatsugu, Associate manager of clinical affairs</name_or_title>
      <organization>Stryker Japan</organization>
      <phone>81 3 6894 8394</phone>
      <email>yasuyuki.inatsugu@stryker.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

